Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS

Azzouz, 1997, Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis, Muscle Nerve, 20, 45, 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H Behse, 1975, Unmyelinated fibres and Schwann cells of sural nerve in neuropathy, Brain, 98, 493, 10.1093/brain/98.3.493 Bradley, 1983, Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis, Ann. Neurol., 14, 267, 10.1002/ana.410140304 Bruijn, 1997, ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions, Neuron, 18, 327, 10.1016/S0896-6273(00)80272-X Deng, 1993, Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase, Science, 261, 1047, 10.1126/science.8351519 Evangelista, 1995, Phrenic nerve conduction in amyotrophic lateral sclerosis, J. Neurol. Sci., 129, 35, 10.1016/0022-510X(95)00057-9 Fischer, 2004, Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man, Exp. Neurol., 185, 232, 10.1016/j.expneurol.2003.10.004 Fraher, 1992, Myelin–axon relationships in the rat phrenic nerve: longitudinal variation and lateral asymmetry, J. Comp. Neurol., 323, 551, 10.1002/cne.903230407 Gurney, 1994, Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation [see comments], Science, 264, 1772, 10.1126/science.8209258 Haenggeli, 2002, Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration, Neurosci. Lett., 335, 39, 10.1016/S0304-3940(02)01140-0 Howland, 2002, Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS), Proc. Natl. Acad. Sci. U. S. A., 99, 1604, 10.1073/pnas.032539299 Kaplan, 1994, Respiratory dysfunction in amyotrophic lateral sclerosis. [Review], Clin. Chest Med., 15, 675, 10.1016/S0272-5231(21)00960-6 Kuzuhara, 1980, Localization of the phrenic nucleus in the rat: a HRP study, Neurosci. Lett., 16, 119, 10.1016/0304-3940(80)90330-4 Miller, 1999, Practice parameter: the care of the patient with amyotrophic lateral sclerosis (An evidence-based review)—Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 52, 1311, 10.1212/WNL.52.7.1311 Nagai, 2001, Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease, J. Neurosci., 21, 9246, 10.1523/JNEUROSCI.21-23-09246.2001 Shaw, 1980, Electrophysiological evaluation of phrenic nerve function in candidates for diaphragm pacing, J. Neurosurg., 53, 345, 10.3171/jns.1980.53.3.0345 Shefner, 2001, Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations, Neurology, 57, 1857, 10.1212/WNL.57.10.1857 Shefner, 2002, Comparison of incremental with multipoint MUNE methods in transgenic ALS mice, Muscle Nerve, 25, 39, 10.1002/mus.10000 Sobue, 1981, Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis, J. Neurol. Sci., 50, 413, 10.1016/0022-510X(81)90153-2 Stambler, 1998, Prognostic indicators of survival in ALS, Neurology, 50, 66, 10.1212/WNL.50.1.66 Stewart, 2001, Electromyography of respiratory muscles in amyotrophic lateral sclerosis, J. Neurol. Sci., 191, 67, 10.1016/S0022-510X(01)00621-9 Swenson, 1992, Phrenic nerve conduction studies, Muscle Nerve, 15, 597, 10.1002/mus.880150511 Tandan, 1985, Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management, Ann. Neurol., 18, 271, 10.1002/ana.410180302 Traynor, 2004, Functional outcome measures as clinical trial endpoints in ALS, Neurology, 63, 1933, 10.1212/01.WNL.0000144345.49510.4E Wong, 1995, An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron, 14, 1105, 10.1016/0896-6273(95)90259-7